CN113913421A - Whole blood DNA extraction reagent and extraction method - Google Patents
Whole blood DNA extraction reagent and extraction method Download PDFInfo
- Publication number
- CN113913421A CN113913421A CN202111487583.1A CN202111487583A CN113913421A CN 113913421 A CN113913421 A CN 113913421A CN 202111487583 A CN202111487583 A CN 202111487583A CN 113913421 A CN113913421 A CN 113913421A
- Authority
- CN
- China
- Prior art keywords
- whole blood
- solution
- tris
- magnetic beads
- blood dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 60
- 210000004369 blood Anatomy 0.000 title claims abstract description 60
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 35
- 238000000605 extraction Methods 0.000 title claims abstract description 33
- 238000007400 DNA extraction Methods 0.000 title claims abstract description 27
- 239000000243 solution Substances 0.000 claims abstract description 63
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims abstract description 62
- 238000005406 washing Methods 0.000 claims abstract description 55
- 239000011324 bead Substances 0.000 claims abstract description 51
- 239000007788 liquid Substances 0.000 claims abstract description 34
- 239000003480 eluent Substances 0.000 claims abstract description 25
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000004094 surface-active agent Substances 0.000 claims abstract description 20
- 108010067770 Endopeptidase K Proteins 0.000 claims abstract description 18
- 239000003381 stabilizer Substances 0.000 claims abstract description 17
- 230000009089 cytolysis Effects 0.000 claims abstract description 16
- 150000002357 guanidines Chemical class 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- 239000007983 Tris buffer Substances 0.000 claims description 15
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 claims description 14
- 229960000789 guanidine hydrochloride Drugs 0.000 claims description 13
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 12
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 12
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 12
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 12
- -1 10M guanidine compound Chemical class 0.000 claims description 8
- 239000006166 lysate Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 7
- ZRALSGWEFCBTJO-UHFFFAOYSA-N anhydrous guanidine Natural products NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 7
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims description 7
- 229960004198 guanidine Drugs 0.000 claims description 7
- 238000011534 incubation Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 5
- 239000000377 silicon dioxide Substances 0.000 claims description 5
- 239000013504 Triton X-100 Substances 0.000 claims description 4
- 229920004890 Triton X-100 Polymers 0.000 claims description 4
- 238000009739 binding Methods 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- DYRVWGXPQZAHMV-UHFFFAOYSA-N cyanamide;guanidine Chemical compound NC#N.NC(N)=N DYRVWGXPQZAHMV-UHFFFAOYSA-N 0.000 claims 1
- 239000002102 nanobead Substances 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 abstract description 25
- 102000039446 nucleic acids Human genes 0.000 abstract description 25
- 108020004707 nucleic acids Proteins 0.000 abstract description 24
- 238000005336 cracking Methods 0.000 abstract description 10
- 239000000725 suspension Substances 0.000 abstract description 10
- 238000000746 purification Methods 0.000 abstract description 4
- 239000006148 magnetic separator Substances 0.000 description 8
- 239000004005 microsphere Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- FYFFGSSZFBZTAH-UHFFFAOYSA-N methylaminomethanetriol Chemical compound CNC(O)(O)O FYFFGSSZFBZTAH-UHFFFAOYSA-N 0.000 description 5
- 229910052814 silicon oxide Inorganic materials 0.000 description 5
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- KBDIEUYACKKLIJ-UHFFFAOYSA-N 2-isocyanatoguanidine Chemical compound NC(=N)NN=C=O KBDIEUYACKKLIJ-UHFFFAOYSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- XNCSCQSQSGDGES-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)C(C)CN(CC(O)=O)CC(O)=O XNCSCQSQSGDGES-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002205 phenol-chloroform extraction Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/1013—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to the technical field of biology, in particular to a whole blood DNA extraction reagent and an extraction method. The whole blood DNA extraction reagent provided by the invention consists of lysis solution, isopropanol, magnetic bead suspension, washing solution I, washing solution II, eluent and proteinase K. Wherein the cracking liquid consists of guanidine compounds, tris (hydroxymethyl) aminomethane, a stabilizer and a surfactant. The reagent is simple and convenient to operate, sample cracking and nucleic acid and magnetic bead combination can be realized on an automatic nucleic acid extractor by one step, the obtained genome DNA is high in content, good in integrity and high in purity, 1-96 samples can be extracted simultaneously, and the rapid, high-flux and fully-automatic extraction and purification of nucleic acid are realized.
Description
Technical Field
The invention relates to the technical field of biology, in particular to a whole blood DNA extraction reagent and an extraction method.
Background
With the rapid development of molecular biology technology, research on the genome level has become a hot point of research. Many conventional experiments of molecular biology are premised on extraction of genomic DNA, whether PCR amplification, gene sequencing or construction of a genomic library, the genomic DNA needs to be extracted, and the quality of the extracted genomic DNA directly affects downstream molecular biology experiments. With the rapid development of modern disease diagnosis technology and precise medical treatment, the amount of samples to be processed is increasing, so that an efficient, reliable and high-throughput DNA extraction method becomes an urgent need in related research fields.
There are various methods for extracting and purifying genome DNA, such as phenol chloroform extraction, SDS method, centrifugal column method and magnetic bead method, and these methods have advantages and disadvantages. The whole blood DNA extraction kit researched based on the method has various types, but the current whole blood DNA extraction kit has various defects in extraction, such as the need of pretreatment of samples, long treatment time, complex extraction process, long extraction process time, easy cross contamination among samples and the like. When the sample size is large, errors are prone to occur, and a large amount of time, manpower and material resources are wasted.
The automatic nucleic acid extractor is an instrument which automatically finishes the extraction work of sample nucleic acid by using matched nucleic acid extraction reagents and is divided into two types: one type is a large-scale automatic instrument, generally called an automatic liquid workstation, which is expensive in price and high in operation cost and is suitable for extracting thousands of samples of the same type at a time. The other type is a small-sized automatic extraction instrument which utilizes a packaged matched reagent to automatically complete the extraction and purification process, and has the advantages of low equipment price, low running cost and convenient operation, thereby being increasingly applied.
The matched reagent of the small-sized automatic extraction instrument has obvious influence on the extraction effect, only a few of current kits can realize high-flux and automatic extraction, and the steps of cell lysis and combination with magnetic beads are required to be separately carried out, so that the complete automation is not realized. Therefore, it is imperative to provide a high-throughput, fully automated whole blood DNA extraction reagent in order to more efficiently incorporate the use of the magnetic bead method for nucleic acid extraction.
Disclosure of Invention
In view of the above, the technical problem to be solved by the present invention is to provide a high-throughput, fully automated whole blood DNA extraction reagent and extraction method
The whole blood DNA extraction reagent provided by the invention comprises lysis solution, magnetic beads, isopropanol, washing solution I, washing solution II, eluent and proteinase K;
the lysis solution comprises: guanidine compounds, tris (hydroxymethyl) aminomethane, stabilizers and surfactants;
the washing solution I comprises: guanidine compounds, tris (hydroxymethyl) aminomethane, stabilizers, surfactants and isopropanol;
the washing liquid II is an ethanol water solution;
the eluent comprises tris.
The whole blood DNA extraction reagent provided by the invention is simple and convenient to operate, can realize sample cracking and nucleic acid and magnetic bead combination on an automatic nucleic acid extractor by one step, has high content of genomic DNA, good integrity and high purity, can simultaneously complete extraction of 1-96 samples, and realizes rapid, high-throughput and fully-automatic extraction and purification of nucleic acid.
In the invention, the lysis solution consists of water and 1M-10M guanidine compounds, 10 mM-50 mM trihydroxymethyl aminomethane, 5 mM-50 mM stabilizer and 1 vol% -10 vol% surfactant.
In the invention, the washing solution I consists of water, 0.5M-5M guanidine compound, 0.1M-1M sodium chloride, 1 mM-10 mM stabilizer, 5 mM-20 mM tris (hydroxymethyl) aminomethane, 0.5 vol% -10 vol% surfactant and 40 vol% -80 vol% isopropanol.
In some embodiments, the guanidine compound is at least one of guanidine hydrochloride or guanidine cyanamide sulfate. The surfactant is at least one selected from Tween-20, Triton X-100 and NP-40. The stabilizer is selected from EDTA or sodium citrate.
In some embodiments, the lysis solution comprises water and 1M to 10M guanidine hydrochloride, 10mM to 50mM tris, 5mM to 50mM EDTA, and 1 vol% to 10 vol% surfactant.
In some embodiments, the washing solution I is composed of water and 0.5M to 5M guanidine hydrochloride, 0.1M to 1M sodium chloride, 1mM to 10mM EDTA, 5mM to 20mM tris, 0.5 vol% to 10 vol% surfactant, and 40 vol% to 80 vol% isopropyl alcohol.
In the invention, the magnetic beads are silicon oxide hydroxyl nano magnetic beads. The diameter of the superparamagnetic silicon oxide hydroxyl nano magnetic microsphere is 100-2000 nm. The magnetic beads of the present invention are present in a suspension of magnetic beads. Wherein the buffer solution for suspending the magnetic beads is 10-80% ethanol water solution. In the adopted magnetic bead suspension, the concentration of the magnetic beads is 5-50 mg/mL. Preferably, the concentration of the magnetic beads is 10 mg/mL.
In the invention, the washing liquid II is ethanol water solution with the volume fraction of 60-100%. Preferably, the washing solution II is ethanol water solution with the volume fraction of 70%.
In the invention, the pH value of the eluent is 7.0-9.0, wherein the concentration of the trihydroxymethyl aminomethane is 0.1 mM-50 mM. Preferably, the concentration of tris in the eluate is 10 mM.
In the present invention, the concentration of proteinase K is 20 mg/mL.
The reagent provided by the invention can be used for preparing a kit for extracting DNA from whole blood.
The whole blood DNA extraction kit comprises the extraction reagent provided by the invention. Other tools or reagents required for extraction may also be included in the kit.
The invention also provides a method for extracting the DNA of the whole blood, which comprises the following steps:
step 1: mixing whole blood, proteinase K, lysis solution, isopropanol and magnetic beads, incubating and reacting, and separating the magnetic beads;
step 2: and (2) washing the magnetic beads separated in the step (1) by a washing solution I and a washing solution II in sequence, eluting by using an eluent, separating the magnetic beads, and taking supernate to obtain a whole blood DNA solution.
In the present invention, the whole blood is fresh whole blood or anticoagulated whole blood. Wherein the anticoagulant has no effect on the extraction result.
In the invention, the volume ratio of the whole blood, the proteinase K, the lysis solution, the isopropanol and the magnetic beads is 200:10:300:300: 10.
In the invention, the incubation reaction conditions in the step 1 comprise incubation at 55 ℃ for 5min and then a binding reaction for 5 min; the elution conditions described in step 2 included incubation at 55 ℃ for 5 min.
The whole blood DNA extraction reagent provided by the invention consists of lysis solution, isopropanol, magnetic bead suspension, washing solution I, washing solution II, eluent and proteinase K. Wherein the cracking liquid consists of guanidine compounds, tris (hydroxymethyl) aminomethane, a stabilizer and a surfactant. The reagent is simple and convenient to operate, sample cracking and nucleic acid and magnetic bead combination can be realized on an automatic nucleic acid extractor by one step, the obtained genome DNA is high in content, good in integrity and high in purity, 1-96 samples can be extracted simultaneously, and the rapid, high-flux and fully-automatic extraction and purification of nucleic acid are realized.
Drawings
FIG. 1 is a diagram showing the comparison of the integrity of the genome in the method of the present invention and the extraction method of the Omega magnetic bead blood extraction kit in example 1;
FIG. 2 is a schematic representation of the addition of reagents to each column of a 96-well plate using the method of the present invention in example 2.
Detailed Description
The invention provides a whole blood DNA extraction reagent and an extraction method, and a person skilled in the art can realize the whole blood DNA extraction reagent by appropriately improving process parameters according to the content in the text. It is expressly intended that all such similar substitutes and modifications which would be obvious to one skilled in the art are deemed to be included in the invention. While the methods and applications of this invention have been described in terms of preferred embodiments, it will be apparent to those of ordinary skill in the art that variations and modifications in the methods and applications described herein, as well as other suitable variations and combinations, may be made to implement and use the techniques of this invention without departing from the spirit and scope of the invention.
The invention provides a whole blood DNA extraction kit based on nano magnetic beads, which consists of lysis solution, isopropanol, magnetic bead suspension, washing solution I, washing solution II, eluent and proteinase K.
The cracking liquid contains guanidine compounds, trihydroxymethyl aminomethane, a stabilizer and a surfactant; the guanidine compound is selected from guanidine hydrochloride, guanidine isocyanate or a combination thereof; the magnetic beads are silicon oxide hydroxyl nano magnetic beads; the washing solution I comprises guanidine compounds, trihydroxymethyl aminomethane, a stabilizer, a surfactant and isopropanol; the surfactant is selected from Tween-20, Triton X-100, NP-40 or the combination thereof; the stabilizer is EDTA or sodium citrate. The washing liquid II is an ethanol solution; the eluent comprises tris.
In the magnetic bead suspension, the magnetic beads are silicon oxide hydroxyl nano magnetic beads, specifically superparamagnetic silicon oxide hydroxyl nano magnetic microspheres, the diameter of which is 100-2000 nm, and the concentration of which is 5-50 mg/mL.
The pH value of the lysis solution is 7.0-10.0, and the lysis solution comprises 1-10M guanidine compounds, 10-50 mM tris (hydroxymethyl) aminomethane, 5-50 mM stabilizer and 1-10% of surfactant. The guanidine compound is selected from guanidine hydrochloride, guanidine isocyanate or a combination thereof.
The washing liquid comprises a washing liquid I and a washing liquid II; the washing solution I contains 0.5-5M guanidine hydrochloride, 0.1-1M sodium chloride, 1-10 mM stabilizer, 5-20 mM tris (hydroxymethyl) aminomethane, 0.5-10% by volume of surfactant and 40-80% by volume of isopropanol. The surfactant is selected from Tween-20, Triton X-100, NP-40 or their combination. The washing liquid II contains ethanol with the volume ratio of 60-100%.
The eluent comprises 0.1-50 mM trihydroxymethyl aminomethane, and the pH value is 7.0-9.0.
The invention provides an application method of the kit for extracting whole blood DNA by a one-step method, which comprises the following steps:
(1) adding frozen anticoagulated whole blood or fresh whole blood, proteinase K, lysate, isopropanol and nano magnetic beads into a new centrifugal tube, uniformly mixing by vortex, incubating for 5 minutes at 55 ℃, reacting for 5 minutes in a combined manner, placing the centrifugal tube on a magnetic separator, and discarding all liquid in an EP tube;
(2) adding the washing solution I into the centrifuge tube, oscillating and uniformly mixing, placing on a magnetic separator, discarding all liquid in the centrifuge tube, and repeating the step once;
(3) adding a washing solution II into the centrifugal tube, oscillating and uniformly mixing, placing on a magnetic separator, and removing all liquid in the centrifugal tube;
(4) adding the eluent into the centrifuge tube, incubating for 5min at 55 deg.C, placing on a magnetic separator, discarding all liquid in the centrifuge tube, transferring the eluent into a new centrifuge tube, and storing at-20 deg.C for use.
Wherein, the lysate added in the step (1) is 200-400 μ L, the isopropanol is 200-400 μ L, the whole blood is 100-300 μ L, and the nano magnetic beads are 50-200 μ L; the washing liquid I and the washing liquid II added in the steps (2) and (3) are 400-1000 mu L; the nucleic acid eluent added in the step (4) is 50-200 mu L.
The invention also provides an application method of the kit for one-step nucleic acid extraction, which comprises the following steps:
(1) sequentially adding frozen anticoagulated whole blood or fresh whole blood, proteinase K, lysate and isopropanol into the 1 st column and the 7 th column of the 96 deep-well plate;
(2) adding nano magnetic beads into the 96 deep-well plate in the 2 nd column and the 8 th column;
(3) adding washing solution I into the 96 deep-hole plate in the 3 rd column and the 9 th column;
(4) adding washing solution I into the 96 deep-hole plate in the 4 th column and the 10 th column;
(5) washing liquid II is added into the 5 th row and the 11 th row of the 96 deep-hole plate;
(6) eluent is added into the 6 th column and the 12 th column of the 96 deep-well plate;
(7) the nucleic acid extractor was run and after completion the eluates from column 6 and column 12 of the 96-well plate were transferred to a new EP tube and stored at-20 ℃ until use.
Wherein, the lysate added in the step (1) is 200-400 mu L, the isopropanol is 200-400 mu L, and the whole blood is 100-300 mu L; adding 50-200 mu L of nano magnetic beads in the step (2); the washing liquid I and the washing liquid II added in the steps (3), (4) and (5) are 400-1000 mu L; the nucleic acid eluent added in the step (6) is 50-200 mu L.
The test materials adopted by the invention are all common commercial products and can be purchased in the market. The invention is further illustrated by the following examples:
example 1
The kit comprises the following seven reagents:
cracking solution: pH 8.5, containing 7MGuanidine hydrochloride50mM tris, 50mM EDTA, 10% Tween-20.
② isopropanol.
③ nanometer magnetic bead suspension: the superparamagnetic silica hydroxyl nano magnetic microsphere has a solution of 30% ethanol, a diameter of 100nm and a concentration of 10 mg/mL.
Fourthly, washing liquid I: 4M guanidine hydrochloride, 1M sodium chloride, 10mM EDTA, 20mM tris (hydroxymethyl) aminomethane, 10% by volume of Tween-20, and 60% by volume of isopropanol.
Washing liquid II: 70% by volume of ethanol
Sixthly, eluent: 10mM Tris, pH 8.0
(iii) protease K: the concentration was 20 mg/mL.
Example 2
The kit comprises the following seven reagents:
cracking solution: pH 9.0, containing 4MCyaniguanidine isosulfate50mM tris, 50mM MEDTA, 1% Tween-20.
② isopropanol.
③ nanometer magnetic bead suspension: the superparamagnetic silica hydroxyl nano magnetic microsphere has a solution of 30% ethanol, a diameter of 100nm and a concentration of 10 mg/mL.
Fourthly, washing liquid I: 4M guanidine hydrochloride, 1M sodium chloride, 10mM EDTA, 20mM tris (hydroxymethyl) aminomethane, 10% by volume of Tween-20, and 60% by volume of isopropanol.
Washing liquid II: 70% by volume of ethanol
Sixthly, eluent: 10mM Tris, pH 8.0
(iii) protease K: the concentration was 20 mg/mL.
Example 3:
the kit comprises the following seven reagents:
cracking solution: the pH was 8.5 and contained 2M guanidine hydrochloride, 50mM Tris, 50mM EDTA, 3% Tween-20.
② isopropanol.
③ nanometer magnetic bead suspension: the superparamagnetic silica hydroxyl nano magnetic microsphere has a solution of 30% ethanol, a diameter of 100nm and a concentration of 10 mg/mL.
Fourthly, washing liquid I: 4M guanidine hydrochloride, 1M sodium chloride, 10mM EDTA, 20mM tris (hydroxymethyl) aminomethane, 10% by volume of Tween-20, and 60% by volume of isopropanol.
Washing liquid II: 70% by volume of ethanol
Sixthly, eluent: 10mM Tris, pH 8.0
(iii) protease K: the concentration was 20 mg/mL.
Example 4
The kit comprises the following seven reagents:
cracking solution: pH 8.5, containing 9M guanidine hydrochloride, 50mM Tris, 50mM EDTA, 3% Tween-20.
② isopropanol.
③ nanometer magnetic bead suspension: the superparamagnetic silica hydroxyl nano magnetic microsphere has a solution of 30% ethanol, a diameter of 100nm and a concentration of 10 mg/mL.
Fourthly, washing liquid I: 4M guanidine hydrochloride, 1M sodium chloride, 10mM EDTA, 20mM tris (hydroxymethyl) aminomethane, 10% by volume of Tween-20, and 60% by volume of isopropanol.
Washing liquid II: 70% by volume of ethanol
Sixthly, eluent: 10mM Tris, pH 8.0
(iii) protease K: the concentration was 20 mg/mL.
Effect verification
The whole blood samples were extracted using the kits of the examples using different methods, respectively:
firstly, a one-step method for extracting DNA from whole blood comprises the following steps:
(1) taking a new centrifuge tube, adding 200 mu L of anticoagulated whole blood or fresh whole blood, 10 mu L of proteinase K, 300 mu L of lysate, 300 mu L of isopropanol and 10 mu L of nano magnetic beads into the centrifuge tube, uniformly mixing by vortex, incubating for 5 minutes at 55 ℃, then carrying out combined reaction for 5 minutes, placing the centrifuge tube on a magnetic separator, and discarding all liquid in an EP tube;
(2) adding 500 mu L of washing solution I into a centrifuge tube, oscillating and uniformly mixing, placing on a magnetic separator, discarding all liquid in the centrifuge tube, and repeating the step once;
(3) adding 500 mu L of washing liquid II into the centrifugal tube, oscillating and uniformly mixing, placing on a magnetic separator, and discarding all liquid in the centrifugal tube;
(4) adding 100 μ L of eluent into the centrifuge tube, incubating at 55 deg.C for 5min, placing on a magnetic separator, discarding all liquid in the centrifuge tube, transferring the eluent into a new centrifuge tube, and storing at-20 deg.C for use.
While the above experiment was completed, the same whole blood sample was extracted using the control reagent Omega magnetic bead method blood genomic DNA extraction kit, and the elution volume was 100. mu.L.
And (3) agarose gel electrophoresis detection: the extracted 6 parts of whole blood DNA were subjected to agarose gel electrophoresis. FIG. 1 shows that the extracted DNA band is single, clear and complete, and has no degradation, and the brightness of the extracted DNA band is equivalent to the effect of the Omega magnetic bead method blood genome DNA extraction kit.
After the kit and the control reagent (Omega magnetic bead method blood genome DNA extraction kit) in the embodiment 1 of the invention are extracted, the concentration and purity of DNA are detected by using an OneDrop 1000 ultra-micro ultraviolet spectrophotometer, and the result is shown in figure 1 and table 1.
TABLE 1
As can be seen from FIG. 1 and Table 1, the kit of the present invention was extracted at the same level of concentration and purity as the Omega magnetic bead method blood genomic DNA extraction kit.
Secondly, an automatic extraction instrument is utilized, the kit of the embodiment 1-4 is adopted to carry out high-flux nucleic acid extraction on the whole blood sample, and the method comprises the following steps:
(1) adding 200 mu L of whole blood, 10 mu L of proteinase K, 300 mu L of lysate and 300 mu L of isopropanol into the 96 deep-well plate in the 1 st column and the 7 th column in sequence;
(2) adding 200 mu L of nano magnetic beads into the 2 nd column and the 8 th column of the 96 deep-well plate;
(3) adding 500 mu L of washing solution I into the 3 rd column and the 9 th column of the 96 deep-well plate;
(4) adding 500 mu L of washing solution I into the 4 th column and the 10 th column of the 96 deep-well plate;
(5) adding 500 mu L of washing solution II into the 5 th row and the 11 th row of the 96 deep-well plate;
(6) adding 100 μ L of eluent into the 6 th column and the 12 th column of the 96 deep-well plate;
(7) operating the nucleic acid extractor, transferring the eluent of the 6 th column and the 12 th column of the 96-deep-hole plate into a new EP tube after the operation is finished,
storing at-20 deg.C for use.
The nucleic acid autosampler program settings are as in table 2.
TABLE 2 nucleic acid auto-extractor program settings
FIG. 2 is a schematic diagram showing a side view of a 96-well plate in which 16 whole blood samples can be processed at a time, in columns 1 to 12, after reagents of the kit of the present invention are added.
After extraction, the DNA concentration and purity were measured with a OneDrop 1000 ultra-micro UV spectrophotometer, the results are shown in tables 3-6.
TABLE 3 detection results of DNA products extracted by the kit of example 1 through the automatic nucleic acid extractor
TABLE 4 detection results of DNA products extracted by the kit of example 2 through the automatic nucleic acid extractor
| Sample (I) | A260nm | A280nm | 230nm | 260/280 | 260/230 | Concentration (ng/. mu.L) |
| 1 | 0.692 | 0.364 | 0.991 | 1.91 | 0.7 | 34.60 |
| 2 | 0.656 | 0.348 | 0.834 | 1.89 | 0.79 | 32.78 |
| 3 | 0.932 | 0.514 | 1.113 | 1.81 | 0.84 | 46.57 |
| 4 | 0.729 | 0.399 | 0.807 | 1.83 | 0.91 | 36.43 |
| 5 | 1.132 | 0.645 | 2.136 | 1.76 | 0.53 | 56.59 |
| 6 | 0.969 | 0.546 | 1.936 | 1.78 | 0.5 | 48.44 |
| 7 | 0.931 | 0.529 | 1.622 | 1.76 | 0.57 | 46.56 |
| 8 | 1.028 | 0.586 | 1.826 | 1.76 | 0.56 | 51.40 |
TABLE 5 detection results of DNA products extracted by the kit from example 3 by the automatic nucleic acid extractor
TABLE 6 detection results of DNA products extracted by the kit of example 4 through the automatic nucleic acid extractor
| Sample (I) | A260nm | A280nm | A230nm | 260/280 | 260/230 | Concentration (ng/. mu.L) |
| 1 | 1.018 | 0.563 | 0.539 | 1.81 | 1.89 | 50.89 |
| 2 | 1.06 | 0.591 | 0.607 | 1.79 | 1.74 | 52.99 |
| 3 | 1.169 | 0.648 | 0.633 | 1.8 | 1.85 | 58.43 |
| 4 | 1.266 | 0.705 | 0.659 | 1.8 | 1.92 | 63.28 |
| 5 | 0.888 | 0.493 | 0.505 | 1.8 | 1.76 | 44.42 |
| 6 | 1.023 | 0.575 | 0.546 | 1.78 | 1.87 | 51.13 |
| 7 | 0.928 | 0.519 | 0.523 | 1.79 | 1.77 | 46.38 |
| 8 | 1.061 | 0.602 | 0.675 | 1.76 | 1.57 | 53.07 |
As can be seen from the results in the table, the DNA obtained by extraction was successfully obtained in each example, wherein the product obtained by extracting the whole blood DNA using the kit of example 1 was high in content and good in purity. Compared with the product obtained by extracting the whole blood DNA with the kit in the embodiment 1, the product obtained by extracting the whole blood DNA with the kit in the embodiment 2-4 has lower content and poorer purity 260/230, which shows that the lysis binding capacity of the whole blood DNA extracted with the lysate is poorer.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that it is obvious to those skilled in the art that various modifications and improvements can be made without departing from the principle of the present invention, and these modifications and improvements should also be considered as the protection scope of the present invention.
Claims (10)
1. The whole blood DNA extraction reagent is characterized by comprising lysis solution, magnetic beads, isopropanol, washing solution I, washing solution II, eluent and proteinase K;
the lysis solution comprises: guanidine compounds, tris (hydroxymethyl) aminomethane, stabilizers and surfactants;
the washing solution I comprises: guanidine compounds, tris (hydroxymethyl) aminomethane, stabilizers, surfactants and isopropanol;
the washing liquid II is an ethanol water solution;
the eluent comprises tris.
2. The whole blood DNA extraction reagent according to claim 1, wherein the lysis solution is composed of water and 1M to 10M guanidine compound, 10mM to 50mM tris, 5mM to 50mM stabilizer, and 1 vol% to 10 vol% surfactant.
3. The whole blood DNA extraction reagent according to claim 1, wherein the washing solution I is composed of water and 0.5M to 5M guanidine compound, 0.1M to 1M sodium chloride, 1mM to 10mM stabilizer, 5mM to 20mM tris (hydroxymethyl) aminomethane, 0.5 vol% to 10 vol% surfactant, and 40 vol% to 80 vol% isopropyl alcohol.
4. The whole blood DNA extraction reagent according to any one of claims 1 to 3, wherein the guanidine compound is at least one of guanidine hydrochloride and guanidine cyanamide iso-sulfate; the stabilizer is at least one of EDTA or sodium citrate; the surfactant is at least one selected from Tween-20, Triton X-100 and NP-40.
5. The whole blood DNA extraction reagent according to claim 1, wherein the magnetic beads are silica hydroxyl nanobeads.
6. The whole blood DNA extraction reagent according to claim 1, wherein the washing solution II is an aqueous ethanol solution having a volume fraction of 60% to 100%.
7. The whole blood DNA extraction reagent according to claim 1, wherein the pH of the eluate is 7.0 to 9.0, and the concentration of tris (hydroxymethyl) aminomethane is 0.1mM to 50 mM.
8. A method for extracting DNA from whole blood, comprising:
step 1: mixing whole blood, proteinase K, lysis solution, isopropanol and magnetic beads, incubating and reacting, and separating the magnetic beads;
step 2: and (2) washing the magnetic beads separated in the step (1) by a washing solution I and a washing solution II in sequence, eluting by using an eluent, separating the magnetic beads, and taking supernate to obtain a whole blood DNA solution.
9. The extraction method according to claim 8, wherein the volume ratio of the whole blood, proteinase K, the lysate, the isopropanol, and the magnetic beads is 200:10:300:300: 10.
10. The extraction method according to claim 8,
the incubation reaction conditions in step 1 include incubation at 55 ℃ for 5min, followed by a binding reaction for 5 min;
the elution conditions described in step 2 included incubation at 55 ℃ for 5 min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111487583.1A CN113913421A (en) | 2021-12-07 | 2021-12-07 | Whole blood DNA extraction reagent and extraction method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111487583.1A CN113913421A (en) | 2021-12-07 | 2021-12-07 | Whole blood DNA extraction reagent and extraction method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113913421A true CN113913421A (en) | 2022-01-11 |
Family
ID=79248873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111487583.1A Pending CN113913421A (en) | 2021-12-07 | 2021-12-07 | Whole blood DNA extraction reagent and extraction method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113913421A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116064503A (en) * | 2023-04-07 | 2023-05-05 | 深圳市梓健生物科技有限公司 | Protease-free rapid magnetic bead method nucleic acid extraction kit and nucleic acid extraction and purification method |
| CN117264945A (en) * | 2023-11-22 | 2023-12-22 | 山东新华医疗器械股份有限公司 | Nucleic acid extraction kit based on magnetic bead method, application thereof and nucleic acid extraction method |
| CN117535283A (en) * | 2024-01-08 | 2024-02-09 | 广州凯普医药科技有限公司 | Kit for extracting blood genome DNA by magnetic bead method and application thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105368820A (en) * | 2015-12-22 | 2016-03-02 | 南京先进激光技术研究院 | Whole blood DNA (deoxyribonucleic acid) extraction kit based on paramagnetic particle method and application of extraction kit |
| CN105420226A (en) * | 2015-12-22 | 2016-03-23 | 南京先进激光技术研究院 | Animal tissue DNA extracting kit based on paramagnetic particle method and application of animal tissue DNA extracting kit |
| CN106636064A (en) * | 2016-12-09 | 2017-05-10 | 洛阳吉恩特生物科技有限公司 | Whole blood genomic DNA high-flux plate type extracting kit and extracting method |
| CN112011534A (en) * | 2019-05-30 | 2020-12-01 | 苏州海狸生物医学工程有限公司 | Saliva genome DNA extraction and purification method based on nano magnetic beads and kit |
| CN112391381A (en) * | 2020-12-02 | 2021-02-23 | 苏州海狸生物医学工程有限公司 | Urine free DNA extraction kit based on nano magnetic beads and extraction method |
| CN112458081A (en) * | 2020-12-02 | 2021-03-09 | 苏州海狸生物医学工程有限公司 | Viral nucleic acid extraction kit based on nanometer magnetic beads |
| CN112553193A (en) * | 2020-12-23 | 2021-03-26 | 苏州中科先进技术研究院有限公司 | Kit for extracting whole blood DNA by paramagnetic particle method and use method thereof |
-
2021
- 2021-12-07 CN CN202111487583.1A patent/CN113913421A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105368820A (en) * | 2015-12-22 | 2016-03-02 | 南京先进激光技术研究院 | Whole blood DNA (deoxyribonucleic acid) extraction kit based on paramagnetic particle method and application of extraction kit |
| CN105420226A (en) * | 2015-12-22 | 2016-03-23 | 南京先进激光技术研究院 | Animal tissue DNA extracting kit based on paramagnetic particle method and application of animal tissue DNA extracting kit |
| CN106636064A (en) * | 2016-12-09 | 2017-05-10 | 洛阳吉恩特生物科技有限公司 | Whole blood genomic DNA high-flux plate type extracting kit and extracting method |
| CN112011534A (en) * | 2019-05-30 | 2020-12-01 | 苏州海狸生物医学工程有限公司 | Saliva genome DNA extraction and purification method based on nano magnetic beads and kit |
| CN112391381A (en) * | 2020-12-02 | 2021-02-23 | 苏州海狸生物医学工程有限公司 | Urine free DNA extraction kit based on nano magnetic beads and extraction method |
| CN112458081A (en) * | 2020-12-02 | 2021-03-09 | 苏州海狸生物医学工程有限公司 | Viral nucleic acid extraction kit based on nanometer magnetic beads |
| CN112553193A (en) * | 2020-12-23 | 2021-03-26 | 苏州中科先进技术研究院有限公司 | Kit for extracting whole blood DNA by paramagnetic particle method and use method thereof |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116064503A (en) * | 2023-04-07 | 2023-05-05 | 深圳市梓健生物科技有限公司 | Protease-free rapid magnetic bead method nucleic acid extraction kit and nucleic acid extraction and purification method |
| CN117264945A (en) * | 2023-11-22 | 2023-12-22 | 山东新华医疗器械股份有限公司 | Nucleic acid extraction kit based on magnetic bead method, application thereof and nucleic acid extraction method |
| CN117535283A (en) * | 2024-01-08 | 2024-02-09 | 广州凯普医药科技有限公司 | Kit for extracting blood genome DNA by magnetic bead method and application thereof |
| CN117535283B (en) * | 2024-01-08 | 2024-03-29 | 广州凯普医药科技有限公司 | Kit for extracting blood genome DNA by magnetic bead method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113913421A (en) | Whole blood DNA extraction reagent and extraction method | |
| US9909118B2 (en) | Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media | |
| CN109722431B (en) | Non-alcohol virus nucleic acid extraction kit based on magnetic bead method | |
| CN114107289B (en) | Nucleic acid extraction kit for fecal samples, preparation method and extraction method | |
| CN105368820A (en) | Whole blood DNA (deoxyribonucleic acid) extraction kit based on paramagnetic particle method and application of extraction kit | |
| US6465639B1 (en) | Method for the isolation of nucleic acid | |
| CN108076644B (en) | Apparatus and method for automatic nucleic acid extraction | |
| CN106591297A (en) | Magnetic bead nucleic acid extraction method | |
| CN107964545A (en) | A kind of kit and its method based on magnetic bead technology extraction fungi/bacterial genomes DNA | |
| CN114058616A (en) | Kit for rapidly extracting free nucleic acid in blood plasma based on paramagnetic particle method | |
| CN111154750A (en) | Method for targeted enrichment of plasma target free DNA | |
| CN111944802A (en) | Fungus nucleic acid extraction lysate and kit and method for extracting nucleic acid | |
| CN110317805B (en) | Nucleic acid fragment sorting and purifying reagent and method | |
| CN106754884B (en) | Kit and application thereof | |
| CN118185922A (en) | Plasma nucleic acid extraction method for enriching fetal free DNA | |
| CN106987588B (en) | Virus/bacteria lysate and fluorescent quantitative PCR detection method | |
| CN113322303A (en) | Nucleic acid extracting solution for paraffin section sample and extracting method | |
| CN116004608B (en) | Method and composition for rapidly extracting nucleic acid | |
| CN116875591A (en) | Kit for extracting free DNA of plasma sample and extraction method | |
| CN116445583A (en) | Pretreatment kit for cell methylation detection sample and use method | |
| CN117165575A (en) | Kit for automatically extracting dry blood spot DNA based on nano magnetic beads | |
| CN115960885A (en) | Method and composition for extracting nucleic acid from heparin sodium sample | |
| CN116103373A (en) | Kit for enriching and amplifying urine eccDNA, method and application | |
| CN116376894A (en) | Kit for extracting blood genome DNA based on magnetic bead technology and extraction method thereof | |
| CN118109459B (en) | Kit for extracting RNA (ribonucleic acid) by magnetic bead method without proteinase k treatment and extraction method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220111 |